Incyte Reports 2016 Fourth-Quarter and Year-End Financial Results, Provides 2017 Financial Guidance and Updates on Key Clinical Programs
Go back to Incyte Reports 2016 Fourth-Quarter and Year-End Financial Results, Provides 2017 Financial Guidance and Updates on Key Clinical Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 124.62 -0.69 (0.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.31 | 52 Week High | $118.49 | |||
| Open | $125.00 | 52 Week Low | $55.00 | |||
| Day High | $127.41 | P/E | N/A | |||
| Day Low | $124.19 | EPS | $-0.56 | |||
| Volume | 811,131 | |||||
